Article Information
- Received July 9, 2012
- Revision received September 10, 2012
- Accepted October 11, 2012
- First published December 5, 2012.
- Version of record published December 5, 2012.
Author Information
- Luca Cocchi1,
- Ivanei E. Bramati2,
- Andrew Zalesky3,
- Emi Furukawa4,
- Leonardo F. Fontenelle2,5,
- Jorge Moll2,
- Gail Tripp4, and
- Paulo Mattos2
- 1Queensland Brain Institute, The University of Queensland, St Lucia, Queensland 4072, Australia,
- 2D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil CEP 22281-100,
- 3Melbourne Neuropsychiatry Centre, The University of Melbourne, Carlton South, Victoria 3053, Australia,
- 4Okinawa Institute of Science and Technology Graduate University (OIST), Okinawa, Japan 904-0495, and
- 5Anxiety and Depression Research Program, Institute of Psychiatry of the Federal University of Rio de Janeiro, Rio de Janeiro, Brazil CEP 22290-140
Author contributions
Author contributions: P.M. designed research; L.C., I.E.B., and P.M. performed research; L.C., I.E.B., and A.Z. analyzed data; L.C., A.Z., E.F., L.F.F., J.M., G.T., and P.M. wrote the paper.
Disclosures
- Received July 9, 2012.
- Revision received September 10, 2012.
- Accepted October 11, 2012.
This study was supported by a joint research agreement between OIST and IDOR. L.C. was supported by the National and International Research Alliance Program from the Queensland Government (Australia). A.Z. is grateful for the support provided by Prof. Trevor Kilpatrick as part of the inaugural Melbourne Neuroscience Institute Fellowship. This work was also supported by the Australian Research Council Grant DP0986320 (to A.Z.). L.F.F., P.M., I.E.B., and J.M. were supported by D'Or Institute for Research and Education Grants. L.F.F. was supported by Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) Awards ID E-26/111.176/2011 and E-26/103.252/2011 and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Award (303846/2008-9). We thank Prof. Jason B. Mattingley and Dr. Natasha Matthews for providing important scientific input to the initial drafts of this manuscript. Dr. Cocchi had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
P.M. was on the speakers' bureau and acted as consultant for Eli-Lilly, Janssen-Cilag, Novartis, and Shire in the last three years. He also received travel awards (air tickets and hotel) to take part in scientific meetings from Janssen-Cilag, Novartis, Eli-Lilly, and Shire in 2010, 2011, and 2012. The Attention-Deficit/Hyperactivity Disorder outpatient program GEDA (Grupo de Estudos do Déficit de Atenção /Institute of Psychiatry) chaired by him received research support from the following pharmaceutical companies in the last three years: Novartis and Shire.
- Correspondence should be addressed to either of the following: Luca Cocchi, Queensland Brain Institute, The University of Queensland, St Lucia 4067, Queensland, Australia, l.cocchi{at}uq.edu.au; or Paulo Mattos, Institute D'Or of Research and Education (IDOR), Rua Diniz Cordeiro 30, Rio de Janeiro, Rio de Janeiro, Brazil CEP 22281-100, Paulo.mattos{at}idor.org
Online Impact
